Top 20 Biosimilar companies 2019 based on total products

The global generics pharmaceutical market is unceasingly growing and increasing with its accessibility & benefits offered as efficient and economical drugs, are always needed in the market. Generics are approved copies of small molecule drugs that contain the same amount of active ingredients, dosage form, safety, strength, route of administration, quality, performance characteristics, as of originally marketed products. The date is diverse and just to create a hassle-free interpretation, we have come up with an insightful bar diagram that depicts that Zydus Cadila retained the topmost position with 21 products in total including 11 still in the pipeline and 10 being the approved ones.